COVID-19: Clinical and Financial Benefits of a DMT

Speaker:

Jane Dickerson, PhD, DABCC; Michael Laposata, MD, PhD

Contact Hours:

1.0

Date:

August 23, 2024 - August 31, 2026

Description:
In this presentation, Dr. Michael Laposata of the University of Texas Medical Branch, discusses the creation and impact of billable, patient-specific, expert-driven interpretation for COVID-19-related test results.
Learning Objectives:
  1. Describe the roles of participants in a diagnostic management team.
  2. Identify the clinical and financial benefits of the COVID-19 DMT.
  3. Discuss the growing complexity of COVID-19 related diagnostic testing.
Back to Lecture Library